CAS: 1844849-10-0
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | PF 06821497 REF: 3D-UYC84910CAS: 1844849-10-0 | Min. 95% | A consultar | Lun 14 Abr 25 |
 | PF-06821497 REF: TM-T12430CAS: 1844849-10-0 | 97.88% | 96,00 €~938,00 € | Lun 16 Jun 25 |
PF 06821497
CAS:1844849-10-0
PF 06821497 is a potential drug for the treatment of Creutzfeldt-Jakob disease (CJD). It is …
Fórmula:
C22H24Cl2N2O5
Pureza:
Min. 95%
Peso molecular:
467.3 g/mol
Ref: 3D-UYC84910
| 5mg | 1.039,00 € | ||
| 10mg | 1.361,00 € | ||
| 25mg | 2.551,00 € | ||
| 50mg | 4.082,00 € |
Entrega estimada en Estados Unidos, el Lunes 14 de Abril de 2025
PF-06821497
CAS:1844849-10-0
PF-06821497 is a selective inhibitor of EZH2 with significant tumor growth inhibition.Cost-effective and quality-assured.
Fórmula:
C22H24Cl2N2O5
Pureza:
97.88%
Forma y color:
Solid
Peso molecular:
467.34
Ref: TM-T12430
| 1mg | 96,00 € | ||
| 5mg | 227,00 € | ||
| 10mg | 354,00 € | ||
| 25mg | 533,00 € | ||
| 50mg | 747,00 € | ||
| 100mg | 938,00 € | ||
| 1mL*10mM (DMSO) | 208,00 € |
Entrega estimada en Estados Unidos, el Lunes 16 de Junio de 2025
